Liquid composition of factor VII polypeptides
    3.
    发明申请
    Liquid composition of factor VII polypeptides 有权
    因子VII多肽的液体组成

    公开(公告)号:US20080227715A1

    公开(公告)日:2008-09-18

    申请号:US12154088

    申请日:2008-05-20

    IPC分类号: A61K38/36 C07K14/745

    摘要: The invention concerns a liquid aqueous composition comprising (i) a factor VII polypeptide, (ii) an agent suitable for keeping pH in the range of from about 4.0 to about 9.0; (iii) an agent selected from the group consisting of: a calcium salt, a magnesium salt, or a mixture thereof; wherein the concentration of (iii) is less than 15 mM; and (iv) An ionic strength modifying agent; wherein the ionic strength of the composition is at least 200 mM.

    摘要翻译: 本发明涉及一种液体含水组合物,其包含(i)因子VII多肽,(ii)适于将pH保持在约4.0至约9.0范围内的试剂; (iii)选自以下的试剂:钙盐,镁盐或其混合物; 其中(iii)的浓度小于15mM; 和(iv)离子强度改性剂; 其中所述组合物的离子强度为至少200mM。

    Liquid composition of factor VII polypeptides
    7.
    发明申请
    Liquid composition of factor VII polypeptides 审中-公开
    因子VII多肽的液体组成

    公开(公告)号:US20060183683A1

    公开(公告)日:2006-08-17

    申请号:US11304429

    申请日:2005-12-15

    IPC分类号: A61K38/36 A61K31/19

    摘要: The invention concerns a liquid aqueous composition comprising (i) a factor VII polypeptide, (ii) an agent suitable for keeping pH in the range of from about 4.0 to about 9.0; (iii) an agent selected from the group consisting of: a calcium salt, a magnesium salt, or a mixture thereof; wherein the concentration of (iii) is less than 15 mM; and (iv) An ionic strength modifying agent; wherein the ionic strength of the composition is at least 200 mM.

    摘要翻译: 本发明涉及一种液体含水组合物,其包含(i)因子VII多肽,(ii)适于将pH保持在约4.0至约9.0范围内的试剂; (iii)选自以下的试剂:钙盐,镁盐或其混合物; 其中(iii)的浓度小于15mM; 和(iv)离子强度改性剂; 其中所述组合物的离子强度为至少200mM。

    Protein stabilization in solution
    10.
    发明申请

    公开(公告)号:US20060160720A1

    公开(公告)日:2006-07-20

    申请号:US11284709

    申请日:2005-11-22

    IPC分类号: A61K38/37 B65D85/42 B65D83/04

    CPC分类号: A61K38/4846

    摘要: Provided are storage containers for proteinaceous pharmaceutical compositions which are characterized in, among other things, comprising (i) a wall portion, wherein an inner wall material thereof is selected from silica-coated glass, silicone-coated glass, polymers of non-cyclic olefins, cycloolefin polymers and cycloolefin/linear olefin copolymers and (ii) one or more closure portions not constituting part of the wall portion, and which contains a formulation of a protein. Also provided are new methods of storing proteinaceous compositions. In one aspect, the stored protein is characterized as having an amino-terminal γ-carboxyglutamic acid (Gla) domain with 9-12 Gla residues.